Chronic Renal Allograft Dysfunction
Top Cited Papers
Open Access
- 1 October 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 16 (10), 3015-3026
- https://doi.org/10.1681/asn.2005050463
Abstract
The major causes of renal transplant loss are death from vascular, malignant or infectious disease, and loss of the allograft from chronic renal dysfunction associated with the development of graft fibrosis and glomerulosclerosis. Chronic allograft nephropathy (CAN) is the histologic description of the fibrosis, vascular and glomerular damage occurring in renal allografts. Clinical programs rely on monitoring change in serum creatinine for identification of patients at risk of CAN, but this change occurs late in the course of the disease, and underestimates the severity of pathologic change. CAN has several causes: ischemia-reperfusion injury, ineffectively or untreated clinical and subclinical rejection, and superimposed calcineurin inhibitor nephrotoxicity, exacerbating pre-existing donor disease. Once established, interstitial fibrosis and arteriolar hyalinosis lead to progressive glomerulosclerosis over the subsequent years. There have been a number of approaches to treatment aimed at reducing the impact of CAN, mostly centered around avoidance of calcineurin inhibitors through their elimination in all, or just selected, patients. These immunosuppression strategies combine corticosteroids with azathioprine or mycophenolate mofetil, and/or sirolimus and everolimus. Late identification of CAN in individual patients has meant that strategies for intervening to prevent chronic renal allograft dysfunction and subsequent graft loss tend to be “too little and far too late.”Keywords
This publication has 81 references indexed in Scilit:
- Ciprofloxacin Decreased Polyoma BK Virus Load in Patients Who Underwent Allogeneic Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2005
- Mycophenolate Mofetil Substitution for Cyclosporine A in Renal Transplant Recipients with Chronic Progressive Allograft Dysfunction: The ???Creeping Creatinine??? Study1Transplantation, 2005
- Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication ratesTransplantation, 2003
- Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant RecipientsThe New England Journal of Medicine, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineThe New England Journal of Medicine, 2001
- Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral NephropathyThe New England Journal of Medicine, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Use of Serum Creatinine Concentrations to Determine Renal Function1Clinical Pharmacokinetics, 1979
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976